Pharmacoeconomic usefulness of the drug Giotrif® (afatinib) in first-line treatment of locally advanced or metastatic non-small cell lung cancer with a mutation of epidermal growth factor receptor (EGFR)
Purpose of the study is to perform first line Giotrif® (afatinib) health economic assessment in patients with metastatic NSCLC with EGFR mutations. Markov model and budget impact model were implemented to simulate afatinib monotherapy in treatment of naïve patients versus one of the chemotherapy com...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IP Habib O.N.
2014-06-01
|
| Series: | Современная онкология |
| Subjects: | |
| Online Access: | https://modernonco.orscience.ru/1815-1434/article/view/26966 |